Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas

Area of Science:

• Oncology
• Pathology
• Angiogenesis Research

Background:

• Gallbladder carcinoma is a significant cause of cancer mortality.
• Angiogenesis plays a crucial role in tumor growth and metastasis.
• The prognostic value of angiogenic factors in gallbladder cancer requires further elucidation.

Purpose of the Study:

• To investigate the angiogenic and prognostic roles of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) in operable gallbladder carcinomas.
• To correlate VEGF and TP expression with angiogenesis and patient survival.
• To identify independent prognostic factors in gallbladder cancer.

Main Methods:

• Immunohistochemical analysis of VEGF, TP, and microvessel density in 60 operable gallbladder carcinoma specimens.
• Correlation of angiogenic factor expression with clinicopathological features and patient prognosis.
• Statistical analysis to determine independent prognostic factors.

Main Results:

• Increased VEGF and TP expression were significantly associated with enhanced angiogenesis.
• High angiogenesis correlated with poor prognosis, but VEGF alone did not predict survival.
• Combined VEGF/TP expression and histological grade were independent predictors of unfavorable patient survival.

Conclusions:

• VEGF and TP are key contributors to angiogenesis in gallbladder carcinoma.
• The combined expression of VEGF and TP is associated with a particularly poor post-operative outcome.
• Angiogenesis, driven by factors like VEGF and TP, is a critical determinant of prognosis in gallbladder cancer.